amlexanox has been researched along with B16 Melanoma in 1 studies
amlexanox: SRA-A antagonist;structure given in first source
amlexanox : A pyridochromene-derived monocarboxylic acid having an amino substituent at the 2-position, an oxo substituent at the 5-position and an isopropyl substituent at the 7-position.
Excerpt | Relevance | Reference |
---|---|---|
"In vivo, we applied a mouse melanoma skin cancer model to assess tumour growth and melanoma-associated pain in IKKε knockout mice as well as C57BL/6 mice after inoculation with IKKε-negative cells." | 1.43 | The protein kinase IKKepsilon contributes to tumour growth and tumour pain in a melanoma model. ( Geisslinger, G; King-Himmelreich, TS; Laarmann, K; Meissner, M; Möser, CV; Niederberger, E; Olbrich, K; Wolters, MC, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Möser, CV | 1 |
Meissner, M | 1 |
Laarmann, K | 1 |
Olbrich, K | 1 |
King-Himmelreich, TS | 1 |
Wolters, MC | 1 |
Geisslinger, G | 1 |
Niederberger, E | 1 |
1 other study available for amlexanox and B16 Melanoma
Article | Year |
---|---|
The protein kinase IKKepsilon contributes to tumour growth and tumour pain in a melanoma model.
Topics: Aminopyridines; Animals; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Proliferation; Humans; I-kapp | 2016 |